When should a repeat colonoscopy be performed after excision of a 0.5 cm tubulovillous (adenoma)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2025 • View editorial policy

From the Guidelines

After excision of a 0.5 cm tubulovillous adenoma, a repeat colonoscopy should be performed in 5-10 years. This recommendation is based on the size and histology of the polyp, which places it in the low-risk adenoma category, as suggested by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society 1. The study found that patients with one or two adenomas, all less than 1 cm in size, with no high-grade dysplasia or villous features, are at lower risk for subsequent advanced adenomas.

Some key points to consider when determining the timing of repeat colonoscopy include:

  • The size of the adenoma, with those less than 1 cm being considered lower risk
  • The histology of the adenoma, with tubulovillous adenomas carrying a higher risk than tubular adenomas but lower risk than villous adenomas
  • The completeness of polyp removal and quality of bowel preparation during the initial colonoscopy
  • Family history of colorectal cancer and the presence of other polyps found during the procedure

According to the guidelines, patients with low-risk adenomas can wait 5 and possibly 10 years for repeat colonoscopy 1. However, if multiple adenomas were found or if there were any high-risk features such as high-grade dysplasia, a shorter surveillance interval of 3 years would be more appropriate. If the colonoscopy reveals no adenomas at the follow-up examination, subsequent colonoscopy can typically be extended to every 5-10 years.

From the Research

Repeat Colonoscopy Recommendations

  • For patients with one or two tubular adenomas that are smaller than 10 mm, a repeat colonoscopy is recommended in 5 to 10 years 2.
  • The European Society of Gastrointestinal Endoscopy (ESGE) recommends that patients with complete removal of 1-4 <10 mm adenomas with low-grade dysplasia, irrespective of villous components, or any serrated polyp <10 mm without dysplasia, do not require endoscopic surveillance and should be returned to screening 3.
  • However, for patients with adenomas that have villous features, such as a 0.5 cm tubulovillous adenoma, surveillance colonoscopy is recommended after 3 years 2, 4.
  • The US Multi-Society Task Force (USMSTF) defines adenomas with tubulovillous or villous histology as high-risk adenomas, and thus recommends surveillance colonoscopy after 3 years 4.

Surveillance Intervals

  • The ESGE recommends surveillance colonoscopy after 3 years for patients with complete removal of at least 1 adenoma ≥10 mm or with high-grade dysplasia, or ≥5 adenomas, or any serrated polyp ≥10 mm or with dysplasia 3.
  • For patients with 1-2 sessile serrated polyps (SSPs) <10 mm and those with 3-4 SSPs <10 mm, the USMSTF recommends surveillance colonoscopy after 5-10 and 3-5 years, respectively 4.
  • A study found that most endoscopists complied with national guidelines and recommended repeat colonoscopy in 3 to 5 years for young patients with neoplastic polyp(s) but no strong family history 5.

Clinical Practice Patterns

  • A survey of gastroenterologists found that 80% of respondents recommend a 10-year screening interval in average-risk patients after normal colonoscopy, and 67% recommend repeat colonoscopy in 5 years for a patient with a family history of colon cancer in a first-degree relative at age 64 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.